
Delta sleep-inducing peptide — natural regulator of deep sleep and circadian rhythms. Discovered in hibernating rabbit brain.
Ranges cited in research literature. Not a usage recommendation. For research use only.
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide — Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu — isolated in 1977 by Guido Schoenenberger and Marcel Monnier in Basel from the cerebral venous blood of rabbits under sleep-inducing thalamic stimulation. It is one of the oldest sleep peptides in the literature and, almost fifty years later, it still has no identified receptor and no clear precursor gene in the human genome, which makes it a peculiar molecule.
In the original rabbit and rat studies it increased slow-wave (delta) sleep, and later work attributed to it effects on LH, GH and somatostatin secretion, on the stress response and on body temperature, with results that varied by model. It has been proposed to act by modulating NMDA receptors and calcium channels, and a phosphorylated fragment is said to be more stable, but none of these hypotheses has been consolidated. Its plasma half-life is minutes.
Human evidence comes from small trials in the 1980s and 1990s in insomnia, chronic pain and withdrawal syndromes, by the intravenous route and with mixed results: some described improved sleep and others no effect. It has not been developed as a drug and is not approved in any country. The research market's subcutaneous convention has no clinical data. Renova distributes it for research only.
| Class | Endogenous nonapeptide associated with slow-wave sleep |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (9 aa) |
| CAS | 62568-57-4 |
| Discovery | Schoenenberger and Monnier, Basel, 1977 (rabbit cerebral blood) |
| Receptor | Not identified; hypotheses: NMDA modulation, calcium channels |
| Half-life | Minutes in plasma |
| Human data | Small IV trials (1980s–90s) in insomnia, pain and withdrawal; mixed results |
| Regulatory status | Not approved in any country |
In 1977, in Basel: Schoenenberger and Monnier stimulated the thalamus of rabbits to induce sleep, collected their cerebral venous blood and infused it into other rabbits, which also fell asleep. Isolating the responsible factor yielded this nonapeptide. Hence its name, delta sleep-inducing peptide.
No. Unlike almost every peptide in the catalog, DSIP has no identified receptor and no clear precursor gene in the human genome. Interactions with NMDA receptors and calcium channels have been proposed, but they remain unconfirmed hypotheses.
They were small, intravenous and decades old: in insomnia some described more slow-wave sleep and others no change; in chronic pain and opioid and alcohol withdrawal there were positive signals without later confirmation. Taken together, the evidence is insufficient for conclusions.
Because in animal studies it altered LH, GH and somatostatin secretion and blunted the corticosterone response to stress, besides affecting body temperature. That diversity of effects without a known receptor is part of what keeps scientific interest in the molecule alive.
Related reading: DSIP: Delta Sleep-Inducing Peptide
Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.
Your cart is empty